ResMed Tops Expectations but Falls Anyway

Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest top-line growth when compared with last quarter, but margin improvements help drive better-than-expected results on the bottom line. 

Let's take a closer look at the company's results to get a better sense of how it fared during the period.

Image source: Getty Images.

Continue reading

Source: Fool.com